This article has been updated to note that Novacyt has not yet received the CE mark for the test but expects it will later this week.
NEW YORK — Novacyt said on Wednesday that it will receive the CE mark for SNPsig VariPlex, a PCR-based test designed to detect multiple SARS-CoV-2 variants of concern, this week.